Temperature-sensitive mutations for live-attenuated Rift Valley fever vaccines: implications from other RNA viruses
- PMID: 26322023
- PMCID: PMC4531298
- DOI: 10.3389/fmicb.2015.00787
Temperature-sensitive mutations for live-attenuated Rift Valley fever vaccines: implications from other RNA viruses
Abstract
Rift Valley fever (RVF) is a mosquito-borne zoonotic disease endemic to the African continent. RVF is characterized by high rate of abortions in ruminants and hemorrhagic fever, encephalitis, or blindness in humans. RVF is caused by the Rift Valley fever virus (RVFV: genus Phlebovirus, family Bunyaviridae). Vaccination is the only known effective strategy to prevent the disease, but there are no licensed RVF vaccines available for humans. A live-attenuated vaccine candidate derived from the wild-type pathogenic Egyptian ZH548 strain, MP-12, has been conditionally licensed for veterinary use in the U.S. MP-12 displays a temperature-sensitive (ts) phenotype and does not replicate at 41°C. The ts mutation limits viral replication at a specific body temperature and may lead to an attenuation of the virus. Here we will review well-characterized ts mutations for RNA viruses, and further discuss the potential in designing novel live-attenuated vaccines for RVF.
Keywords: MP-12; Rift Valley fever virus; bunyavirus; temperature sensitivity; vaccine.
Figures

Similar articles
-
The L, M, and S Segments of Rift Valley Fever Virus MP-12 Vaccine Independently Contribute to a Temperature-Sensitive Phenotype.J Virol. 2016 Jan 27;90(7):3735-44. doi: 10.1128/JVI.02241-15. J Virol. 2016. PMID: 26819307 Free PMC article.
-
Rift Valley fever vaccines: an overview of the safety and efficacy of the live-attenuated MP-12 vaccine candidate.Expert Rev Vaccines. 2017 Jun;16(6):601-611. doi: 10.1080/14760584.2017.1321482. Epub 2017 May 2. Expert Rev Vaccines. 2017. PMID: 28425834 Free PMC article. Review.
-
Rift Valley Fever Virus MP-12 Vaccine Is Fully Attenuated by a Combination of Partial Attenuations in the S, M, and L Segments.J Virol. 2015 Jul;89(14):7262-76. doi: 10.1128/JVI.00135-15. Epub 2015 May 6. J Virol. 2015. PMID: 25948740 Free PMC article.
-
Risk analysis of inter-species reassortment through a Rift Valley fever phlebovirus MP-12 vaccine strain.PLoS One. 2017 Sep 19;12(9):e0185194. doi: 10.1371/journal.pone.0185194. eCollection 2017. PLoS One. 2017. PMID: 28926632 Free PMC article.
-
Single-cycle replicable Rift Valley fever virus mutants as safe vaccine candidates.Virus Res. 2016 May 2;216:55-65. doi: 10.1016/j.virusres.2015.05.012. Epub 2015 May 27. Virus Res. 2016. PMID: 26022573 Free PMC article. Review.
Cited by
-
Viral Inhibition of the IFN-Induced JAK/STAT Signalling Pathway: Development of Live Attenuated Vaccines by Mutation of Viral-Encoded IFN-Antagonists.Vaccines (Basel). 2016 Jun 29;4(3):23. doi: 10.3390/vaccines4030023. Vaccines (Basel). 2016. PMID: 27367734 Free PMC article. Review.
-
The L, M, and S Segments of Rift Valley Fever Virus MP-12 Vaccine Independently Contribute to a Temperature-Sensitive Phenotype.J Virol. 2016 Jan 27;90(7):3735-44. doi: 10.1128/JVI.02241-15. J Virol. 2016. PMID: 26819307 Free PMC article.
-
The Temperature-Associated Effects of Rift Valley Fever Virus Infections in Mosquitoes and Climate-Driven Epidemics: A Review.Viruses. 2025 Feb 1;17(2):217. doi: 10.3390/v17020217. Viruses. 2025. PMID: 40006972 Free PMC article. Review.
-
Temperature Sensitive Mutations in Influenza A Viral Ribonucleoprotein Complex Responsible for the Attenuation of the Live Attenuated Influenza Vaccine.Viruses. 2018 Oct 15;10(10):560. doi: 10.3390/v10100560. Viruses. 2018. PMID: 30326610 Free PMC article. Review.
-
Rift Valley fever vaccines: an overview of the safety and efficacy of the live-attenuated MP-12 vaccine candidate.Expert Rev Vaccines. 2017 Jun;16(6):601-611. doi: 10.1080/14760584.2017.1321482. Epub 2017 May 2. Expert Rev Vaccines. 2017. PMID: 28425834 Free PMC article. Review.
References
-
- Bird B. H., Maartens L. H., Campbell S., Erasmus B. J., Erickson B. R., Dodd K. A., et al. (2011). Rift Valley fever virus vaccine lacking the NSs and NSm genes is safe, nonteratogenic, and confers protection from viremia, pyrexia, and abortion following challenge in adult and pregnant sheep. J. Virol. 85 12901–12909. 10.1128/JVI.06046-11 - DOI - PMC - PubMed
Publication types
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources